Daniel is a member of our life sciences patent team.
Daniel has a Master’s degree in Chemistry and a DPhil in Biochemistry from the University of Oxford. For his Masters project he studied the synthesis and conformational properties of extended molecular switches. During his DPhil he investigated the biophysical properties of membrane-active peptides and proteins using a variety of established and novel biophysical techniques and models. He also spent time at Harvard Medical School for postdoctoral work, researching biologically-active, chemically-modified peptides.
Daniel joined Mewburn Ellis LLP in 2017.